Bayer Looks To Scratch Antitrust Suit Over Flea, Tick Med
Bayer HealthCare has urged a California federal judge to jettison a competitor's antitrust suit, saying the action can't prove Bayer unlawfully dominated sales of a topical flea and tick medication through...To view the full article, register now.
Already a subscriber? Click here to view full article